A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars
Clinical trial NCT00892723 · COMPLETED
Trial details
- NCT number
- NCT00892723
- Sponsor
- Capstone Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-09-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.